Trials / Completed
CompletedNCT01529645
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
Phase I, Randomized, Controlled, Observer-Blind, Dose-Ranging Study of Acellular Pertussis and Tetanus-Diptheria-Acellular Pertussis Booster Vaccine in Adults Ages 18 to 40 Years.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 420 (actual)
- Sponsor
- Novartis Vaccines · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the safety and efficacy of 9 different vaccines containing aP (acellular pertussis) and TdaP (acellular pertussis, tetanus and diphtheria) in healthy subjects 18 to 40 years of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Acellular pertussis vaccine | Acellular pertussis (aP) vaccine was administered with different antigen doses intramuscularly in the upper deltoid region of the subject's non-dominant arm. |
| BIOLOGICAL | Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed) | Tetanus, reduced diphtheria, and acellular pertussis (TdaP) vaccine was administered with different antigen doses intramuscularly in the upper deltoid region of the subject's non-dominant arm. |
| BIOLOGICAL | Licensed TdaP booster vaccine | Licenced TdaP booster vaccine was administered intramuscularly in the upper deltoid region of the subject's non-dominant arm. |
| BIOLOGICAL | Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany) | To ensure all subjects receive a tetanus and diphtheria booster vaccination, an injection was administered on Study Day 30, one month after the administration of the investigational vaccine. |
| OTHER | Saline solution | Subjects received one injection of saline solution at one month after vaccination. |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2012-07-01
- Completion
- 2013-07-01
- First posted
- 2012-02-09
- Last updated
- 2016-04-04
- Results posted
- 2014-09-18
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01529645. Inclusion in this directory is not an endorsement.